Table 4 Maternal and neonatal clinical factors associated with NFH.

From: Proposing a machine learning-based model for predicting nonreassuring fetal heart

Outcome

RFH (n = 6506)

NFH (n = 661)

P-value

Preeclampsia

  

0.046

No

6132 (94.3)

610 (92.3)

 

Yes

373 (5.7)

51 (7.7)

 

Diabetes

  

0.295

No

5552 (85.3)

561 (84.9)

 

Yes

953 (14.7)

100 (15.1)

 

Hypothyroidism

  

0.999

No

5839 (89.8)

594 (89.9)

 

Yes

666 (10.2)

67 (10.1)

 

Cardiovascular disease

  

0.225

No

6440 (99.0)

651 (98.5)

 

Yes

65 (1.0)

10 (1.5)

 

COVID-19

  

0.110

No

6402 (98.4)

645 (97.6)

 

Yes

103 (1.6)

16 (2.4)

 

Chronic hypertension

  

0.522

No

6442 (99.0)

657 (99.4)

 

Yes

63 (1.0)

4 (0.6)

 

Maternal anemia

  

0.903

No

6318 (97.1)

643 (97.3)

 

Yes

187 (2.9)

18 (2.7)

 

Chorioamnionitis

  

0.873*

No

6483 (99.7)

659 (99.7)

 

Yes

22 (0.3)

2 (0.3)

 

Placenta abruption

  

< 0.01

No

6305 (96.9)

623 (94.3)

 

Yes

200 (3.1)

38 (5.7)

 

Placenta acreta

  

0.413*

No

6490 (99.8)

661 (100)

 

Yes

15 (0.2)

0

 

Drug addiction

  

0.826

No

6449 (99.1)

655 (99.1)

 

Yes

56 (0.9)

6 (0.9)

 

Intrauterine growth restriction

  

< 0.001

No

6303 (96.9)

622 (94.1)

 

Yes

202 (3.1)

39 (5.9)

 

Meconium amniotic fluid

  

0.056

No

5620 (86.4)

566 (85.6)

 

Yes

885 (13.6)

95 (14.4)

 

Newborn sex

  

< 0.001

Male

3294 (50.6)

393 (59.5)

 

Female

3211 (49.4)

268 (40.5)

 
  1. Data are presented as n (%).
  2. NFH: Nonreassuring fetal heart; RFH: Reassuring fetal heart.
  3. *Based on Fisher’s exact test.